Intestinal Pseudo-obstruction Treatment Market Analysis

  • Report ID: 5760
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Intestinal Pseudo-obstruction Treatment Market Analysis

Drug Class (Antibiotic, Antidepressants, Antidiarrheal)

The antibiotic segment in the intestinal pseudo-obstruction treatment market will grow the most by the forecast period and will hold almost 68% because of its extensive use in people across the world to treat intestinal pseudo-obstruction. Doctors cure chronic intestinal pseudo-obstruction with nutrition help, medicines, ease, and sometimes surgery. If a fundamental health issue is causing chronic intestinal pseudo-obstruction, doctors will also cure the basic health issue as required. According to the original description, Ogilvie attributed the large bowel colic to a violation of the sympathetic supply because of retroperitoneal spitefulness leaving the parasympathetic innervation unopposed. The shortage of inhibitory inputs would produce a neuropathophysiological instability leading to fitful colonic contraction causing a hindrance. The proximal bowel would then become heavily dilated under the impact of parasympathetic nerve trails.

Diagnosis (Physical Exam, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Manometry)

The blood test segment in the intestinal pseudo-obstruction treatment market is expected to hold 38% of the revenue share owing to the increasing blood tests to detect the disease of intestinal pseudo-obstruction. Intestinal pseudo-obstruction is an unusual situation that can be tough to diagnose because your symptoms can mimic other maladies. With a team of gastrointestinal motility specialists and a devoted Neurogastroenterology, Motility, and Functional Disorders Program, they surpass in promptly and precisely diagnosing your situation at Stanford Health Care. Once they comprehend the source of your discomfort, they provide customized treatments so you can begin to feel better. A substitute hypothesis acknowledges the potential that tonic hyperactivity of exterior or interior inhibitory neurones may play a crucial role in the pathophysiology of Ogilvie’s syndrome.

Our in-depth analysis of the global intestinal pseudo-obstruction treatment market includes the following segments:

     Type

  • Acute
  • Chronic

     Treatment

  • Medication
  • Surgery
  • Diet
  • Decompression

     Diagnosis

  • Physical Exam
  • Biopsy
  • Blood Test
  • Gastric Emptying Tests
  • Imaging Tests, Manometry

     Symptoms

  • Abdominal Pain
  • Bloating
  • Diarrhea
  • Vomiting
  • Nausea
  • Constipation

     Dosage

  • Tablet
  • Injection

     Route of Administration

  • Oral
  • Intravenous

     End-User

  • Clinic
  • Hospital

     Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

     Drug Class

  • Antibiotic
  • Antidepressants
  • Antidiarrheal
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5760
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intestinal pseudo-obstruction treatment is evaluated at USD 25.32 billion.

The intestinal pseudo-obstruction treatment market size was valued at USD 24.33 billion in 2024 and is set to exceed USD 46.45 billion by 2037, expanding at over 5.1% CAGR during the forecast period i.e., between 2025-2037. The increased frequency of gastrointestinal disease will drive the market growth.

North America industry is anticipated to account for largest revenue share of 45% by 2037, owing to increasing advancement in the tools of diagnosis in this region.

The major players in the market are GlaxoSmithKline Plc., Abbott Laboratories, Pfizer Inc., Johnson & Johnson, Callisto Pharmaceuticals Inc., Biogen Inc., Novartis A.G., Canila Healthcare Ltd, AbbVie Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited., Daiichi Sankyo Co Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample